Correspondence 0001140361-24-046170 from Kronos Bio, Inc. (KRON) (CIK 0001741830)
Kronos Bio, Inc. (KRON) (CIK 0001741830)
Date: Nov. 12, 2024 · CIK: 0001741830 · Accession: 0001140361-24-046170
AI Filing Summary & Sentiment
File numbers found in text: 333-283072
Show Raw Text
CORRESP
1
filename1.htm
KRONOS BIO, INC.
1300 So. El Camino Real, Suite 400
San Mateo, California 94402
November 12, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Tim Buchmiller
Re:
Kronos Bio, Inc.
Registration Statement on Form S-3 (File No. 333-283072)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Kronos Bio, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on November 14, 2024, at
4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Charles J. Bair of Cooley LLP and Asa M. Henin of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Asa M. Henin at (858)
550-6104, or in his absence, Charles J. Bair at (858) 550-6142.
Very truly yours,
Kronos Bio, Inc.
/s/ Norbert Bischofberger, Ph.D.
By:
Norbert Bischofberger, Ph.D.
Title:
President and Chief Executive Officer